Unkila-Kallio L, Leminen A, Tiitnen A, Lehtovirta P, Wahlström T, Ylikorkala O
Department of Obstetrics and Gynecology, Helsinki University Hospital, Finland.
Acta Obstet Gynecol Scand. 1997 Feb;76(2):177-81. doi: 10.3109/00016349709050077.
Many questions have been raised recently about the relationship between infertility, fertility drugs and cancer. This prompted us to evaluate our patients having ovarian or breast cancer with a known history of infertility.
We report thirteen women who had been examined and/or treated for infertility before the occurrence of malignant tumors of the ovary or the breast at an age under 50 years in 1990-1995 in our unit.
Mean age of the patients was 35 years (s.d. 5.9 years, range 28-47 years). Of the 11 ovarian tumors, one was a malignant teratoma, two were granulosa cell tumors and eight epithelial ovarian cancers. Ten women had received either clomiphene citrate alone or together with gonadotrophins, one had used only gonadotrophins, and in two patients ovarian cancer was detected during an infertility work-up but before any treatment. Four women had used clomiphene for more than twelve cycles. Two patients had ductal breast cancer.
Our patients emphasize the need for follow-up and long-term prospective studies in infertile women who have been evaluated or treated for infertility.
最近,关于不孕症、促孕药物与癌症之间的关系引发了诸多问题。这促使我们对有不孕症病史的卵巢癌或乳腺癌患者进行评估。
我们报告了1990年至1995年间在我们科室年龄小于50岁、在卵巢或乳腺发生恶性肿瘤之前接受过不孕症检查和/或治疗的13名女性。
患者的平均年龄为35岁(标准差5.9岁,范围28 - 47岁)。在11例卵巢肿瘤中,1例为恶性畸胎瘤,2例为颗粒细胞瘤,8例为上皮性卵巢癌。10名女性单独使用过枸橼酸氯米芬或与促性腺激素联合使用,1名女性仅使用过促性腺激素,2名患者在不孕症检查期间但在任何治疗之前被检测出卵巢癌。4名女性使用氯米芬超过12个周期。2例患者患有导管乳腺癌。
我们的患者强调,对于接受过不孕症评估或治疗的不孕女性,需要进行随访和长期前瞻性研究。